Drug · DIN 02099225
FLUOTIC
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 22, 2007; first marketed December 31, 1995.
- Drug Identification Number (DIN)
- 02099225
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Enteric-Coated)
- Route
- Oral
- Therapeutic class (ATC)
- Sodium fluoride A12CD01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SODIUM FLUORIDE | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 16, 2006: NOC 7966New Drug Submission (NDS) · Manufacturer name change
- August 17, 2000: NOC 1474New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “fluotic”. A notice may cover another product or only some lots: read it to see what it covers.